Risks of HIV/AIDS Deaths Increase on Episodic Antiretroviral Therapy

Armen Hareyan's picture

HIV/AIDS Treatment


Results from one of the largest HIV/AIDS treatment trials ever conducted show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause. In the study, the investigators used two predetermined levels of CD4+ T cells, the primary immune cell targeted by HIV, to guide them in respectively suspending or restarting the study participants on antiretroviral therapy.

A report describing this research

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.